Abbott Settles HIV Antitrust Suit With Indirect Buyers
Abbott Laboratories has reached a proposed settlement with a class of indirect purchasers of HIV medication Norvir that alleged that Abbott unfairly hiked the drug's price after competitors started threatening Abbott's...To view the full article, register now.
Already a subscriber? Click here to view full article